Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen

Journal of Virology

Volumn 72, Issue 6, 1998, Pages 4746-4755

  Wrona, Thomas J ^a,c   Lozano, Mary ^a   Binhazim, Awadh A ^b   Dudley, Jaquelin P ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Arnold White and Durkee   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; SUPERANTIGEN; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE AMPLIFICATION; LONG TERMINAL REPEAT; MALE; MOLECULAR CLONING; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 0031902831     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.6.4746-4755.1998     Document Type: Article

References (70)

1. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459-486.
2. Ando, Y., W. Wajjwalku, N. Niimi, K. Hiromatsu, T. Morishima, and Y. Yoshikai. 1995. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain. J. Immunol. 154:6219-6226.
3. Beutner, U., E. Kraus, D. Kitamura, K. Rajewsky, and B. T. Huber. 1994. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1457-1466.
4. Bramblett, D., C.-L. L. Hsu, M. Lozano, K. Earnest, C. Fabritius, and J. Dudley. 1995. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat. J. Virol. 69:7868-7876.
5. Brandt-Carlson, C., J. S. Butel, and D. Wheeler. 1993. Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins. Virology 193:171-185.
6. Cavin, C., and E. Buetti. 1995. Tissue-specific and ubitquitous factors binding next to the glucocorticoid receptor modulate transcription from the mouse mammary tumor virus promoter. J. Virol. 69:3759-3770.
7. Choi, Y., J. W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of the mouse mammary tumour virus. Nature 350:203-207.
8. Choi, Y., P. Marrack, and J. W. Kappler. 1992. Structural analysis of a mouse mammary tumor virus superantigen. J. Exp. Med. 175:847-852.
9. Dickinson, L. A., C. D. Dickinson, and T. Kohwi-Shigematsu. 1997. An atypical homeodomain in SATB1 promotes specific recognition of the key structural element in a matrix attachment region. J. Biol. Chem. 272:11463-11470.
10. Dudley, J. 1994. Mouse mammary tumor virus, p. 853-861. In R. G. Webster and A. Granoff (ed.), Encyclopedia of virology. Academic Press, New York, N.Y.
11. Dudley, J., and R. Risser. 1984. Amplification and novel locations of endogenous mouse mammary tumor virus genomes in mouse T-cell lymphomas. J. Virol. 49:92-101.
12. Dudley, J. P., and H. E. Varmus. 1981. Purification and translation of murine mammary tumor virus mRNA's. J. Virol. 39:207-218.
13. Elliott, J. F., B. Pohajdak, D. J. Talbot, J. Shaw, and V. Paetkau. 1988. Phorbol diester-inducible, cyclosporine-suppressible transcription from a novel promoter within the mouse mammary tumor virus env gene. J. Virol. 62:1373-1380.
14. Golovkina, T. V., A. Chervonsky, J. P. Dudley, and S. R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69:637-645.
15. Golovkina, T. V., J. P. Dudley, A. B. Jaffe, and S. R. Ross. 1995. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection. Proc. Natl. Acad. Sci. USA 92:4828-4832.
16. Golovkina, T. V., A. B. Jaffe, and S. R. Ross. 1994. Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range. J. Virol. 68:5019-5026.
17. Golovkina, T. V., I. Piazzon, I. Nepomnaschy, V. Buggiano, M. de Olano Vela, and S. R. Ross. 1997. Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J. Virol. 71:3895-3903.
18. Golovkina, T. V., J. A. Prescott, and S. R. Ross. 1993. Mouse mammary tumor virus-induced tumorigenesis in sag transgenic mice: a laboratory model of natural selection. J. Virol. 67:7690-7694.
19. Gunzburg, W. H., F. Heinemann, S. Wintersperger, T. Miethke, H. Wagner, V. Erfle, and B. Salmons. 1993. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature 364: 154-158.
20. Held, W. H., H. Acha-Orbea, H. R. MacDonald, and G. A. Waanders. 1994. Superantigens and retroviral infection: insights from mouse mammary tumor virus. Immunol. Today 15:184-190.
21. Held, W., G. A. Waanders, A. N. Shakhov, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529-540.
22. Hsu, C. L., C. Fabritius, and J. Dudley. 1988. Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat. J. Virol. 62:4644-4652.
23. Huang, M., J. W. Lee, and D. O. Peterson. 1993. Functional redundancy of octamer elements in the mouse mammary tumor virus promoter. Nucleic Acids Res. 21:5235-5241.
24. Ignatowicz, L., J. W. Kappler, P. Marrack, and M. T. Scherer. 1994. Identification of two Vβ7-specific viral superantigens. J. Immunol. 152:65-71.
25. Janeway, C. A. 1991. Mls: makes a little sense. Nature 349:459-461.
26. Jouvin-Marche, E., P. A. Cazenave, D. Voegtle, and P. N. Marche. 1992. Vβ17 T-cell deletion by endogenous mammary tumor virus in wild-type-derived mouse strain. Proc. Natl. Acad. Sci. USA 89:3232-3235.
27. Jouvin-Marche, E., P. N. Marche, A. Six, C. Liebe-Gris, D. Voegtle, and P. A. Cazenave. 1993. Identification of an endogenous mammary tumor virus involved in the clonal deletion of Vβ2 T cells. Eur. J. Immunol. 23:2758-2764.
28. Kang, J. J., T. Schwegel, and J. E. Knepper. 1993. Sequence similarity between the long terminal repeat coding regions of mammary-tumorigenic BALB/cV and renal-tumorigenic C3H-K strains of mouse mammary tumor virus. Virology 196:303-308.
29. Karapetian, O., A. N. Shakhov, J.-P. Kraehenbuhl, and H. Acha-Orbea. 1994. Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model. J. Exp. Med. 180:1511-1516.
30. Kingston, R. E., P. Chomczynski, and N. Sacchi. 1991. Guanidinium methods for total RNA preparation, p. 4.2.1-4.2.9. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
31. Klement, V., W. P. Rowe, J. W. Hartley, and W. E. Pugh. 1969. Mixed culture cytopathogenicity: a new test for growth of murine leukemia viruses in tissue culture. Proc. Natl. Acad. Sci. USA 63:753-758.
32. Korman, A. J., P. Bourgarel, T. Meo, and G. E. Rieckhof. 1992. The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein. EMBO J. 11:1901-1905.
33. Kozak, C., G. Peters, R. Pauley, V. Morris, R. Michalides, J. Dudley, M. Green, M. Davisson, O. Prakash, A. Vaidya, J. Hilgers, A. Verstraeten, N. Hynes, H. Diggelmann, D. Peterson, J. C. Cohen, C. Dickson, N. Sarkar, R. Nusse, H. Varmus, and R. Callahan. 1987. A standardized nomenclature for endogenous mouse mammary tumor viruses. J. Virol. 61:1651-1654.
34. Lambert, J. F., H. Acha-Orbea, E. Kolb, and H. Diggelmann. 1993. The 3′ half of the mouse mammary tumor virus orf gene is not sufficient for its superantigen function in transgenic mice. Mol. Immunol. 30:1399-1404.
35. Lee, F. S., T. F. Lane, A. Kuo, G. Shackleford, and P. Leder. 1995. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 mice. Proc. Natl. Acad. Sci. USA 92:2268-2272.
36. Lee, J. W., P. G. Moffitt, K. L. Morley, and D. O. Peterson. 1991. Multipartite structure of a negative regulatory element associated with a steroid hormone-inducible promoter. J. Biol. Chem. 266:24101-24108.
37. Liu, J. Unpublished data.
38. Liu, J., D. Bramblett, Q. Zhu, M. Lozano, R. Kobayashi, S. R. Ross, and J. P. Dudley. 1997. The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression. Mol. Cell. Biol. 17:5275-5287.
39. MacArthur, C. A., D. B. Shankar, and G. M. Shackleford. 1995. Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis. J. Virol. 69:2501-2507.
40. Marchetti, A., F. Buttitta, S. Miyazaki, D. Gallahan, G. H. Smith, and R. Callahan. 1995. Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J. Virol. 69: 1932-1938.
41. Marrack, P., E. Kushnir, and J. Kappler. 1991. A maternally inherited superantigen encoded by a mammary tumour virus. Nature 349:524-526.
42. Miller, C. L., R. Garner, and V. Paetkau. 1992. An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene. Mol. Cell. Biol. 12:3262-3272.
43. Mink, S., E. Hartig, P. Jennewein, W. Doppler, and A. C. Cato. 1992. A mammary cell-specific enhancer in mouse mammary tumor virus DNA is composed of multiple regulatory elements including binding sites for CTF/NFI and a novel transcription factor, mammary cell-activating factor. Mol. Cell. Biol. 12:4906-4918.
44. Morley, K. L., M. G. Toohey, and D. O. Peterson. 1987. Transcriptional repression of a hormone-responsive promoter. Nucleic Acids Res. 15:6973-6989.
45. Nandi, S., and C. M. McGrath. 1973. Mammary neoplasia in mice. Adv. Cancer Res. 17:353-414.
46. Niimi, N., W. Wajjwalku, Y. Ando, N. Nakamura, M. Ueda, and Y. Yoshikai. 1995. A novel Vβ2-specific endogenous mouse mammary tumor virus which is capable of producing a milk-borne exogenous virus. J. Virol. 69:7269-7273.
47. Palmiter, R. D. 1974. Magnesium precipitation of ribonucleoprotein complexes. Expedient techniques for the isolation of undegraded polysomes and messenger ribonucleic acid. Biochemistry 13:3606-3615.
48. Payvar, F., D. DeFranco, G. L. Firestone, B. Edgar, O. Wrange, S. Okret, J. A. Gustafsson, and K. R. Yamamoto. 1983. Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell 35:381-392.
49. Rosenwasser, O. A., S. Fairchild, and K. Tomonari. 1993. New superantigen specificity created by two amino acid replacements. Immunogenetics 38: 367-369.
50. Shackleford, G. M., C. A. MacArthur, H. C. Kwan, and H. E. Varmus. 1993. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4. Proc. Natl. Acad. Sci. USA 90:740-744.
51. Shackleford, G. M., and H. E. Varmus. 1988. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc. Natl. Acad. Sci. USA 85:9655-9659.
52. Sherer, M. T., L. Ignatowicz, A. Pullen, J. Kappler, and P. Marrack. 1995. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire. J. Exp. Med. 182:1493-1504.
53. Skalnik, D. G., E. C. Strauss, and S. H. Orkin. 1991. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J. Biol. Chem. 266:16736-16744.
54. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
55. Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327-341.
56. a superantigen-specific T cell responses. J. Exp. Med. 175:1405-1408.
57. Valarche, I., J.-P. Tissier-Seta, M.-R. Hirsch, S. Martinez, C. Goridis, and J.-F. Brunet. 1993. The mouse homeodomain protein Phox2 regulates Ncam promoter activity in concert with Cux/CDP and is a putative determinant of neurotransmitter phenotype. Development 119:881-896.
58. van Zonneveld, A.-J., S. A. Curriden, and D. J. Loskutoff. 1988. Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter. Proc. Natl. Acad. Sci. USA 85:5525-5529.
59. Varmus, H., and R. Swanstrom. 1985. Replication of retroviruses, p. 75-134. In R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), Molecular biology of tumor viruses: RNA tumor viruses, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor. New York, N.Y.
60. Vieira, J., and J. Messing. 1982. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19:259-268.
61. Waanders, G. A., A. N. Shakhov, W. Held, O. Karapetian, H. Acha-Orbea, and H. R. MacDonald. 1993. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J. Exp. Med. 177:1359-1366.
62. Wrona, T., and J. P. Dudley. 1996. Major histocompatibility complex class II I-E-independent transmission of C3H mouse mammary tumor virus. J. Virol. 70:1246-1249.
63. Xu, L., S. Haga, S. Imai, and N. H. Sarkar. 1994. Cloning in a plasmid of an MMTV from a wild Chinese mouse: sequencing of the viral LTR. Virus Res. 33:167-178.
64. Xu, L., T. J. Wrona, and J. P. Dudley. 1996. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression. Virology 215:113-123.
65. Xu, L., T. J. Wrona, and J. P. Dudley. 1997. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene. Virology 236:54-65.
66. Yanagawa, S.-I., K. Kakimi, H. Tanaka, A. Murakami, Y. Nakagawa, Y. Kubo, Y. Yamada, H. Hiai, K. Kuribayashi, T. Masuda, and A. Ishimoto. 1993. Mouse mammary tumor virus with rearranged long terminal repeats causes murine lymphomas. J. Virol. 67:112-118.
67. Yang, J. N., and J. Dudley. 1992. Endogenous Mtv-8 or a closely linked sequence stimulates rearrangement of the downstream Vκ9 gene. J. Immunol. 149:1242-1251.
68. Yazdanbakhsh, K., C. G. Park, G. M. Winslow, and Y. Choi. 1993. Direct evidence for the role of COOH terminus of mouse mammary tumor virus superantigen in determining T cell receptor Vβ specificity. J. Exp. Med. 178: 737-741.
69. Yoshimoto, T., H. Nagase, H. Nakano, A. Matsuzawa, and H. Nariuchi. 1994. A Vβ8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice. Eur. J. Immunol. 24:1612-1619.
70. Yoshimoto, T., H. Nagase, H. Nakano, A. Matsuzawa, and H. Nariuchi. 1996. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor β-chain variable region. Virology 223:387-391.